Présentation :

• Consultation d'oncologie médicale, en particulier ORL, tumeurs rares, endocrinologique, gynécologique et générale
• Médecin superviseur du tour des salles des patients hospitalisés
• Maître de stage pour les médecins en formation en Oncologie médicale
• Hospitalisation de jour pour les chimiothérapies, transfusions et tous traitements intraveineux
• Participation aux réunions multidisciplinaires oncologiques
• Membre
  • de l'International Breast Cancer Study Group (IBCSG),
  • de la Belgian Society of Oncology (BSMO),
  • d’un groupe local d’évaluation médicale (GLEM) en Oncologie,
  • de l’European Society of Medical Oncology (ESMO).

Spécialité(s) :

ONCOLOGIE MEDICALE

Localisation(s) :

• Citadelle

• Study of the efficacy of pamidronate in recurrences of tumor-induced hypercalcemia.
  JJ.Body, JC.Dumon, I.Louviaux et al. Bone and Mineral (april 1994) 25 suppl 1 :S78
• A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer .
  C.Poole, M.Adams, V.Barley, J.Graham, D.Kerr, I.Louviaux, T.Perren, M.Piccart, H.Thomas. Annals of Oncology (1996) 7 : suppl. 5, abstr. 322O
• Docetaxel activity in a compassionate-use program for « poor-risk » metastatic breast cancer : a single center experience.
  Z.Kusenda, F.Geurs, J.Kerger, I.Louviaux, G.Berchem, A.Awada, S.Bartholomeus, J.Selleslags, and M.Piccart.
  Annals of Oncology (1996) 7 : suppl. 5, abstr. 102P
• CD34+ selection from autologous thawed PBPC : report of a patient with successful engraftment .
  A.Delforge, C.De Bruyne, M.Marevoet, I.Louviaux, C.Jacquy, M.Massy, R.Badjou, D.Bron, P.Stryckmans.
  Institut Bordet, Brussels. ISHAGE 3e Congrès, Bordeaux , mai 1997
• Decreased efficacy of biphosphonates for recurrences of tumor-induced hypercalcemia-mechanisms and influence of the tumor type.
  JJ.Body, I.Louviaux, JC.Dumon
  Proceedings of ASCO (1998) volume 17, abstr. 169 - category : AIDS and supportive care
• Cytogenetic abnormalities in Waldenström's disease (WD) : a single center study on 45 cases.
  I.Louviaux, L.Michaux, A.Hagemeijer, A.Criel, J.Billiet, J.M.Scheiff, V.Deneys, A.Delannoy, A.Ferrant.( Intr. by JL.Michaux ).
  Department of hematology, Clin. Univ. St Luc, Brussels ; Center for Human Genetics, KUL Leuven ; Laboratorium Hematology, AZ St Jan, Brugge, Belgium
  Blood (1998), vol. 92, N° 10, supplem. 1 (part 2 of 2), abstr. 3775
  14th General Meeting of the Belgian Hematological Society (BHS) , February 19-20, 1999,Genval, Belgium, abstr. P 43
• Digital clubbing in a patient with progressive mantle cell lymphoma.
  I.Louviaux, E.Van Den Neste, J.M.Scheiff, L.Michaux, N.Straetmans and A.Ferrant.
  Annals of Hematology (1999) 78 : 29-31
• Phase I/II study of 2-chloro-2'-deoxyadenosine (cda) in combination with cyclophosphamide (cp) in patients (pts) with advanced low grade lymphoid malignancies.
  E.Van Den Neste, I.Louviaux, A.Delannoy, J.L.Michaux, A.Bosly, L.Michaux, A.Sonet, C.Doyen, M.Meyns, M.André, P.Mineur, N.Straetmans and A.Ferrant.
  Groupe UCL d' Hematologie, Catholic University of Louvain, Belgium
  Blood (1998), vol. 92, N° 10, supplem. 1 (part 2 of 2), abstr. 4224
  14th General Meeting of the Belgian Hematological Society (BHS) , February 19-20, 1999,Genval, Belgium, abstr. O 5.
• Potentiation of antitumor effects of cyclophosphamide in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine.
  E.Van Den Neste, F.Bontemps, A.Delacauw, S.Cardoen, I.Louviaux, J.M.Scheiff, E.Gillis, A.Ferrant and G.Van den Berghe .
  Leukemia (1999) 13 : 918-925.
• Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine.
  E.Van Den Neste, I.Louviaux, J.L.Michaux, A.Delannoy, L.Michaux, J.M.Scheiff, A.Bosly , N.Straetmans and A.Ferrant .
  British Journal of Hematology (1999) 105 : 268-270.
• Chemotherapy for malignant mesothelioma : a quantitative and qualitative overview of the litterature.
  T.Berghmans, M.Paesmans, Y.Lalami, F.Lemaître, I.Louviaux, S.Luce, R.Pegrimcova, Ph.Vermylen and J.P.Sculier
  (European Lung Cancer Working Party ELCWP ), Jules Bordet Institute, Brussels, Belgium.
  Proceedings of ASCO (1999)volume 18 : 481(a), abstr. 1858 (P)
  Malignant pleural mesothelioma, Lignano Sabbiadoro , Italy, march 18-19, 1999
• Phase I/II study of 2-chloro-2'deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
  E.Van Den Neste, I.Louviaux, JL.Michaux, A.Delannoy, L.Michaux, A.Sonet, A.Bosly, C.Doyen, P.Mineur, M.André, N.Straetmans, E.Coche, C.Venet, T.Duprez, A.Ferrant.
  Leukemia (2000) 14,1136-1142.
• Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
  JJ.Body, I.Louviaux, JC.Dumon. Support Care Cancer (2000) 8 : 398-404 
• Response of global fibrinolytic capacity to desmopressin acetate and relationship with euglobulin clot lysis time.
  Ph.Cauchie, K.Zouaoui Boudjeltia, N.Deschepper, I.Louviaux, CHU André Vésale, Montigny le tilleul, Université Libre de Bruxelles, Belgium.
  16th International Congress On Thrombosis , Porto, Portugal, may 5-8, 2000 (P)
• Optimization of morphine ampoules for injection.
  J.Douchamps, J.Andris, V.Douchamps, S.Mirza, E.Gilbart, D.Jacob, I.Louviaux.
  22nd Internat. Symposium on Intensive Care and Emergency Medicine, Brussels , Belgium, 19-22 march 2002 (P)
• Activity of chemotherapy and immunotherapy on malignant mesothelioma : a systematic review of the literature with meta-analysis.
  T.Berghmans, M.Paesmans, Y.Lalami, I.Louviaux, S.Luce, C.Mascaux, A.P.Meert, J.P.Sculier.
  Lung Cancer (2002) 38: 111-121.
• Management of resectable non-small cell lung cancer.
  Guidelines of clinical practice made by the European Lung Cancer Working Party.
  C.G.Alexopoulos, T.Berghmans, M.C.Berchier, B.Colinet, D.Dequanter, A.Efremidis, M.C.Florin, V.Giner, S.Jouveshomme, G.Koumakis, J.J.Lafitte, J.Lecomte, J.Lemaitre, I.Louviaux, C.Mascaux, A.P.Meert, V.Ninane, M.Richez, J.P.Sculier, B.Stach, M.Vaslamatzis, P.Wackenier.
  Rev Med Brux (2006) 27 : 29-38 (in french).
• Management of unresectable non-metastatic small cell lung cancer.
  Guidelines of clinical practice made by the European Lung Cancer Working Party.
  C.G.Alexopoulos, M.C.Berchier, T.Berghmans, Y.Bonduelle, B.Colinet, T.Collon, D.Dequanter, A.Efremidis, C.El Khawad, M.C.Florin, V.Giner, S.Holbrechts, G.Koumakis, J.J.Lafitte, J.Lecomte, J.Lemaitre, P.Lothaire, I.Louviaux, E.Maetz, C.Mascaux, A.P.Meert, V.Ninane, P.Ravez, M.Roelandts, A.Scherpereel, J.P.Sculier, P.Van Houtte, M.Vaslamatzis, P.Wackenier.
  Rev Med Brux (2006) 27 : 152-61 (in french).
• Treatment of non-small cell lung cancer : advanced (metastatic) disease.
  Guidelines of clinical practice made by the European Lung Cancer Working Party.
  M.C. Berchier, T. Berghmans, Y. Bonduelle, B. Colinet, T. Collon, S. Desurmont, A. Efremidis, X. Ficheroulle, M.C. Florin, V. Giner, S. Holbrechts, G. Koumakis, J.J Lafitte,N. Leclercq, I. Louviaux, E. Markiewicz, C. Mascaux, A.P. Meert, M. Paesmans, P. Ravez, M. Richez, M. Roelandts, J.P. Sculier, C. Tulippe, O. Van Cutsem, P. Van Houtte, M. Vaslamatzis, P. Wackenier.
  Rev Med Brux (2007) 28 : 495-511 (in french).
• European Lung Cancer Working Party clinical practice guidelines.
  Small cell lung cancer: V. Extensive disease.
  C.G.Alexopoulos, M.C.Berchier, T.Berghmans, Y.Bonduelle, B.Colinet, T.Collon, M.Dusart, X. Ficheroulle, V.Giner, A.Kotsori, J.J.Lafitte, N.Leclercq, J.Lecomte, I.Louviaux, E.Markiewicz, C.Mascaux, M.Paesmans, M.Richez, M.Roelandts, J.P.Sculier, P.Van Houtte, P.Wackenier.
  Hospital Chronicles (2007) 2(3):118-134
• Treatment of small cell lung cancer: limited diseases.
  Guidelines of clinical practice made by the European Lung Cancer Working Party.
  C.G.Alexopoulos, M.C.Berchier, T.Berghmans, Y.Bonduelle, B.Colinet, X. Ficheroulle, V.Giner, K.Kotsori, J.J.Lafitte, I.Louviaux, C.Mascaux, A.P.Meert, M.Paesmans, M.Richez, M.Roelandts, A.Scherpereel, J.P.Sculier, P.Van Houtte, P.Wackenier.
  Rev Med Brux (2008) 29 : 159-67 (in french).